Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER

Spatial models of tumour evolution

Spatiotemporal modelling of tumours detects at least two distinct models of cancer evolution and reveals the influence of necrosis in enhancing the metastatic potential in both models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Models of fitness acquisition in human tumours.

References

  1. Fu, X. Y. et al. Nat. Ecol. Evol. https://doi.org/10.1038/s41559-021-01586-x (2021).

  2. Bignold, L. P., Coghlan, B. L. D. & Jersmann, H. P. A. in David Paul Von Hansemann: Contributions to Oncology Ch. 5 (Birkhauser, 2007).

  3. Fialkow, P. J. Biochim. Biophys. Acta Rev. Cancer 458, 283–321 (1976).

    Article  CAS  Google Scholar 

  4. Fidler, I. J. & Kripke, M. L. Science 197, 893–895 (1977).

    Article  CAS  Google Scholar 

  5. Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).

    Article  CAS  Google Scholar 

  6. Zhao, Y. et al. Nat. Ecol. Evol. 5, 1033–1045 (2021).

    Article  CAS  Google Scholar 

  7. Turajlic, S. et al. Cell 173, 581–594.e12 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Kimryn Rathmell.

Ethics declarations

Competing interests

W.K.R. has received research support from Incyte Corp and her spouse is a founder, scientific advisory board member and stockholder of Sitryx Therapeutics, a scientific advisory board member and stockholder of Caribou Biosciences, a member of the scientific advisory board of Nirogy Therapeutics, has consulted for Merck, Pfizer and Mitobridge within the past three years, and has received research support from Incyte Corp., Calithera Biosciences and Tempest Therapeutics. D.K.G. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaines, D.K., Rathmell, W.K. Spatial models of tumour evolution. Nat Ecol Evol 6, 26–27 (2022). https://doi.org/10.1038/s41559-021-01584-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41559-021-01584-z

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer